SCHEMBL13747871

SCHEMBL13747871

CCCC[C@H](O)[C@H](C)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.50
MAPK1 P28482 1/20 0.50
GPR84 Q9NQS5 7/20 0.48
FFAR1 O14842 1/20 0.48
ACE2 Q9BYF1 1/20 0.44
ABCB1 P08183 1/20 0.44
SPHK1 Q9NYA1 1/20 0.43
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42
MAPT P10636 1/20 0.42
LCK P06239 1/20 0.42
PPARD Q03181 1/20 0.42
ZDHHC20 Q5W0Z9 1/20 0.42
ZDHHC2 Q9UIJ5 1/20 0.42
CHRM1 P11229 1/20 0.41
AKR1A1 P14550 1/20 0.41
CHRM3 P20309 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7805104 1.00 CA2 (0.50) CA2MAPK1GPR84FFAR1ACE2
SCHEMBL17527088 1.00 CA2 (0.50) CA2MAPK1GPR84FFAR1ACE2
SCHEMBL7761200 1.00 CA2 (0.50) CA2MAPK1GPR84FFAR1ACE2
SCHEMBL3680620 0.93 GPR84 (0.57) GPR84FFAR1ACE2ABCB1SPHK1
SCHEMBL7083484 0.91 GPR84 (0.61) GPR84FFAR1ACE2ABCB1SPHK1
SCHEMBL2498859 0.91 GPR84 (0.61) GPR84FFAR1ACE2ABCB1SPHK1
SCHEMBL22552585 0.91 GPR84 (0.61) GPR84FFAR1ACE2ABCB1SPHK1
SCHEMBL22552779 0.91 GPR84 (0.61) GPR84FFAR1ACE2ABCB1SPHK1
SCHEMBL1271078 0.91 GPR84 (0.61) GPR84FFAR1ACE2ABCB1SPHK1
SCHEMBL7075692 0.91 GPR84 (0.61) GPR84FFAR1ACE2ABCB1SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009103953-A1 TREATMENT OF ENERGY UTILIZATION DISEASE SUMMIT CORPORATION PLC (GB) 2009-08-27 WO disclosed